A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice

Virology
Jason A WickerAlan D T Barrett

Abstract

West Nile virus (WNV) NS4B is a small hydrophobic nonstructural protein that is hypothesized to participate both in viral replication and evasion of host innate immune defenses. The protein has four cysteine residues (residues 102, 120, 227, and 237). Since cysteines are often critical for the function of proteins, each of the four cysteine residues found in WNV NS4B was mutated to serine by site-directed mutagenesis. While three of these substitutions had little effect on replication or mouse virulence phenotypes, the C102S mutation was associated with a temperature-sensitive phenotype at 41 degrees C as well as attenuation of the neuroinvasive and neurovirulence phenotypes in mice.

References

Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C S HahnC M Rice
Aug 17, 2001·Circulation·R SoRelle
Mar 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexander G PletnevDavid W Vaughn
Nov 26, 2002·Biochemical and Biophysical Research Communications·Wen Yan TongHak Hotta
Dec 28, 2002·Journal of Virology·Monica A McArthurAlan D T Barrett
Apr 15, 2003·Journal of Virology·Marika LundinMats A A Persson
Jun 16, 2005·Journal of Virology·Jorge L Muñoz-JordánAdolfo García-Sastre

❮ Previous
Next ❯

Citations

Jul 12, 2013·Journal of Neurovirology·Brenda L Fredericksen
Nov 20, 2009·Journal of Virology·I Fernandez-SainzM V Borca
Mar 30, 2010·The American Journal of Tropical Medicine and Hygiene·Ryo MurataIkuo Takashima
May 3, 2011·Emerging Infectious Diseases·Anna PapaNorbert Nowotny
Oct 3, 2013·Viruses·Samantha Brandler, Frederic Tangy
Dec 5, 2013·Viruses·Siew Pheng Lim, Pei-Yong Shi
Dec 20, 2013·International Journal of Environmental Research and Public Health·Hiroaki KariwaIkuo Takashima
Dec 25, 2013·PloS One·Emilie DonadieuMuriel Coulpier
Sep 22, 2010·Vector Borne and Zoonotic Diseases·Marietjie Venter, Robert Swanepoel
May 6, 2011·Current Infectious Disease Reports·Roberta L Debiasi
Nov 26, 2014·Viruses·Yan-Jang S HuangDana L Vanlandingham
Jul 22, 2014·Viruses·Willy W SuenHelle Bielefeldt-Ohmann
Sep 22, 2015·Journal of Virological Methods·Daya V PavitrakarVijay P Bondre
Jun 30, 2006·Trends in Neurosciences·Anthony N van den Pol
Nov 2, 2012·The Journal of General Virology·Ezequiel Balmori MelianAlexander A Khromykh
Feb 9, 2012·Virology·Jason A WickerAlan D T Barrett
Apr 12, 2011·Virology·Michelle AudsleyAlexander A Khromykh
Feb 9, 2008·Emerging Infectious Diseases·Elizabeth M BothaMarietjie Venter
Jul 3, 2009·Veterinary Microbiology·Zsuzsanna TapasztiTamás Bakonyi
Mar 24, 2015·Antiviral Research·Xuping XiePei-Yong Shi
Jan 10, 2012·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Kendra N Pesko, Gregory D Ebel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.